ESC 365 - Using NT-proBNP to screen patients with afib: results from the STROKESTOP II trial.

Open Access

Using NT-proBNP to screen patients with afib: results from the STROKESTOP II trial.

Session: Cardiac biomarkers are here to stay

Topic: Biomarkers

Speaker: Doctor K. Kemp Gudmundsdottir (Stockholm, SE)

Sponsored by Roche Diagnostics International

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Doctor Katrin Kemp Gudmundsdottir

Karolinska Institutet Danderyd Hospital, Stockholm (Sweden)

5 presentations

0 follower

4 more presentations in this session

Introduction.

Speaker: Doctor D. Gualandro (Basel, CH)

The value of high-sensitivity troponin T in patients undergoing noncardiac surgery.

Speaker: Doctor C. Puelacher (Innsbruck, AT)

The value of NT-proBNP in cardiovascular risk stratification and optimization of cardioprotective treatment among patients with type 2 diabetes.

Speaker: Doctor M. Vaduganathan (Boston, US)

Live Q&A.

Access the full session

Cardiac biomarkers are here to stay

Speakers: Doctor K. Kemp Gudmundsdottir, Doctor D. Gualandro, Doctor C. Puelacher, Doctor M. Vaduganathan

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources